Supernus Pharmaceuticals holds special stockholder meeting
INDV•Supernus Pharmaceuticals shareholders adopted the merger agreement with Indivior at a special meeting on October 15, 2026.
1. Merger agreement adopted
Supernus Pharmaceuticals shareholders adopted the merger agreement with Indivior at a special meeting on October 15, 2026. Under the agreement, Artemis Merger Sub would merge into Supernus, leaving Supernus as a wholly owned subsidiary of Indivior.
